JANE STREET GROUP, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRW and the CUSIP is G3141W122. A total of 27 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$970
-35.9%
26,838
-1.4%
0.00%
Q4 2022$1,513
+51.3%
27,218
+1.5%
0.00%
Q3 2022$1,000
-50.0%
26,813
-3.1%
0.00%
Q2 2022$2,000
-60.0%
27,670
+4.0%
0.00%
Q1 2022$5,000
-66.7%
26,611
+0.0%
0.00%
Q4 2021$15,000
-21.1%
26,600
-0.2%
0.00%
Q3 2021$19,000
-32.1%
26,640
+0.2%
0.00%
Q2 2021$28,000
-15.2%
26,6000.0%0.00%
Q1 2021$33,00026,6000.00%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 66,666$656,0000.02%
Altium Capital Management LP 133,333$25,0000.01%
Radcliffe Capital Management, L.P. 33,333$329,0000.01%
Granite Point Capital Management, L.P. 133,332$25,0000.01%
COWEN AND COMPANY, LLC 187,227$35,0000.00%
683 Capital Management, LLC 200,000$37,0000.00%
KINGDON CAPITAL MANAGEMENT, L.L.C. 66,665$11,0000.00%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 333,333$62,0000.00%
HealthCor Management, L.P. 78,059$15,0000.00%
CVI Holdings, LLC 115,985$20,0000.00%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders